Cargando…

Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis

Recent evidence suggests that reactive oxygen species (ROS) produced by inflammatory cells drive axonal degeneration in active multiple sclerosis (MS) lesions by inducing mitochondrial dysfunction. Mitochondria are endowed with a variety of antioxidant enzymes, including peroxiredoxin-3 and thioredo...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijland, Philip G, Witte, Maarten E, van het Hof, Bert, van der Pol, Susanne, Bauer, Jan, Lassmann, Hans, van der Valk, Paul, de Vries, Helga E, van Horssen, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268800/
https://www.ncbi.nlm.nih.gov/pubmed/25492529
http://dx.doi.org/10.1186/s40478-014-0170-2
_version_ 1782349290469851136
author Nijland, Philip G
Witte, Maarten E
van het Hof, Bert
van der Pol, Susanne
Bauer, Jan
Lassmann, Hans
van der Valk, Paul
de Vries, Helga E
van Horssen, Jack
author_facet Nijland, Philip G
Witte, Maarten E
van het Hof, Bert
van der Pol, Susanne
Bauer, Jan
Lassmann, Hans
van der Valk, Paul
de Vries, Helga E
van Horssen, Jack
author_sort Nijland, Philip G
collection PubMed
description Recent evidence suggests that reactive oxygen species (ROS) produced by inflammatory cells drive axonal degeneration in active multiple sclerosis (MS) lesions by inducing mitochondrial dysfunction. Mitochondria are endowed with a variety of antioxidant enzymes, including peroxiredoxin-3 and thioredoxin-2, which are involved in limiting ROS-induced damage. In this study, we explored the distribution and role of the mitochondrial antioxidants peroxiredoxin-3 and thioredoxin-2 as well as their regulator peroxisome proliferator-activated receptor gamma coactivator1-alpha (PGC-1α) in MS pathogenesis. Immunohistochemical analysis of a large cohort of MS patients revealed a striking upregulation of PGC-1α and downstream mitochondrial antioxidants in active demyelinating MS lesions. Enhanced expression was predominantly observed in reactive astrocytes. To elucidate the functional role of astrocytic PGC-1α in MS pathology, we generated human primary astrocytes that genetically overexpressed PGC-1α. Upon an oxidative insult, these cells were shown to produce less ROS and were found to be more resistant to ROS-induced cell death compared to control cells. Intriguingly, also neuronal cells co-cultured with PGC-1α-overexpressing astrocytes were protected against an exogenous oxidative attack compared to neuronal cells co-cultured with control astrocytes. Finally, enhanced astrocytic PGC-1α levels markedly reduced the production and secretion of the pro-inflammatory mediators interleukin-6 and chemokine (C-C motif) ligand 2. Our findings suggest that increased astrocytic PGC-1α in active MS lesions might initially function as an endogenous protective mechanism to dampen oxidative damage and inflammation thereby reducing neurodegeneration. Activation of PGC-1α therefore represents a promising therapeutic strategy to improve mitochondrial function and repress inflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0170-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4268800
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42688002014-12-17 Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis Nijland, Philip G Witte, Maarten E van het Hof, Bert van der Pol, Susanne Bauer, Jan Lassmann, Hans van der Valk, Paul de Vries, Helga E van Horssen, Jack Acta Neuropathol Commun Research Recent evidence suggests that reactive oxygen species (ROS) produced by inflammatory cells drive axonal degeneration in active multiple sclerosis (MS) lesions by inducing mitochondrial dysfunction. Mitochondria are endowed with a variety of antioxidant enzymes, including peroxiredoxin-3 and thioredoxin-2, which are involved in limiting ROS-induced damage. In this study, we explored the distribution and role of the mitochondrial antioxidants peroxiredoxin-3 and thioredoxin-2 as well as their regulator peroxisome proliferator-activated receptor gamma coactivator1-alpha (PGC-1α) in MS pathogenesis. Immunohistochemical analysis of a large cohort of MS patients revealed a striking upregulation of PGC-1α and downstream mitochondrial antioxidants in active demyelinating MS lesions. Enhanced expression was predominantly observed in reactive astrocytes. To elucidate the functional role of astrocytic PGC-1α in MS pathology, we generated human primary astrocytes that genetically overexpressed PGC-1α. Upon an oxidative insult, these cells were shown to produce less ROS and were found to be more resistant to ROS-induced cell death compared to control cells. Intriguingly, also neuronal cells co-cultured with PGC-1α-overexpressing astrocytes were protected against an exogenous oxidative attack compared to neuronal cells co-cultured with control astrocytes. Finally, enhanced astrocytic PGC-1α levels markedly reduced the production and secretion of the pro-inflammatory mediators interleukin-6 and chemokine (C-C motif) ligand 2. Our findings suggest that increased astrocytic PGC-1α in active MS lesions might initially function as an endogenous protective mechanism to dampen oxidative damage and inflammation thereby reducing neurodegeneration. Activation of PGC-1α therefore represents a promising therapeutic strategy to improve mitochondrial function and repress inflammation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s40478-014-0170-2) contains supplementary material, which is available to authorized users. BioMed Central 2014-12-10 /pmc/articles/PMC4268800/ /pubmed/25492529 http://dx.doi.org/10.1186/s40478-014-0170-2 Text en © Nijland et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Nijland, Philip G
Witte, Maarten E
van het Hof, Bert
van der Pol, Susanne
Bauer, Jan
Lassmann, Hans
van der Valk, Paul
de Vries, Helga E
van Horssen, Jack
Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title_full Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title_fullStr Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title_full_unstemmed Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title_short Astroglial PGC-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
title_sort astroglial pgc-1alpha increases mitochondrial antioxidant capacity and suppresses inflammation: implications for multiple sclerosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268800/
https://www.ncbi.nlm.nih.gov/pubmed/25492529
http://dx.doi.org/10.1186/s40478-014-0170-2
work_keys_str_mv AT nijlandphilipg astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT wittemaartene astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT vanhethofbert astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT vanderpolsusanne astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT bauerjan astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT lassmannhans astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT vandervalkpaul astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT devrieshelgae astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis
AT vanhorssenjack astroglialpgc1alphaincreasesmitochondrialantioxidantcapacityandsuppressesinflammationimplicationsformultiplesclerosis